GT
PRVA icon

Glenmede Trust’s Privia Health PRVA Stock Holding History

Glenmede Trust’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
44,111
+177
+0.4% +$4.1K 0.01% 729
2026
Q1 		$904K Sell
43,934
-14,795
-25% -$333K ﹤0.01% 769
2025
Q4 		$1.39M Buy
+58,729
New +$1.43M 0.01% 639
2025
Q1 		$1.33M Sell
59,455
-2,299
-4% -$53.4K 0.01% 635
2024
Q4 		$1.21M Sell
61,754
-173
-0.3% -$3.43K 0.01% 660
2024
Q3 		$1.13M Sell
61,927
-456
-0.7% -$8.7K 0.01% 683
2024
Q2 		$1.08M Buy
62,383
+168
+0.3% +$2.98K 0.01% 669
2024
Q1 		$1.22M Sell
62,215
-2,035
-3% -$43K 0.01% 666
2023
Q4 		$1.48M Sell
64,250
-43,461
-40% -$973K 0.01% 614
2023
Q3 		$2.48M Buy
107,711
+976
+0.9% +$24.8K 0.01% 485
2023
Q2 		$2.95M Hold
106,735
– – 0.02% 459
2023
Q1 		$2.95M Sell
106,735
-4,348
-4% -$115K 0.02% 460
2022
Q4 		$2.52M Sell
111,083
-8,000
-7% -$223K 0.01% 486
2022
Q3 		$4.05M Buy
+119,083
New +$4.4M 0.03% 411

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Glenmede Trust's PRVA Position: Q2 2026 in Review

Glenmede Trust increased its Privia Health (PRVA) stake by 0.4% in Q2 2026, buying an estimated $4.1K and bringing the position to 44,111 shares worth $1.13M. The position accounts for 0.01% of the portfolio, ranked #729.

Glenmede Trust first reported a position in PRVA in Q3 2022 and has held it in 14 quarters since. The position peaked at $4.05M in Q3 2022. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Glenmede Trust held 44,111 shares of Privia Health worth $1.13M as of Q2 2026.
  • Glenmede Trust bought 177 Privia Health shares in Q2 2026, an estimated $4.1K.
  • Privia Health made up 0.01% of Glenmede Trust's portfolio in Q2 2026, its #729 holding.
  • Glenmede Trust first reported a position in Privia Health in Q3 2022 and has held it in 14 quarters since.
  • Glenmede Trust's Privia Health position peaked at $4.05M in Q3 2022.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.